Jeffrey Sean Healey - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Medicine (Internal), Faculty of Health Sciences
Associate Member, Health Research Methods, Evidence, and Impact, Faculty of Health Sciences
Professor, Medicine, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Contact
View All

selected scholarly activity

chapters
- The Case for and against Implantable Cardioverter Defibrillators in Patients with Coronary Artery Disease. 1174-1177. 2009
- Clinical Trials of Pacing Modes. 337-356. 2007
- Clinical trials of pacing modes. 337-356. 2006
conferences
- Residual Stroke Risk Among Atrial Fibrillation Patients Treated With Warfarin or Novel Oral Anticoagulants: A Patient Level MetaAnalysis From Combine AF. Circulation. 2023
- Alcohol Consumption and Arrhythmia Recurrence After Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis. Circulation. 2022
- Alcohol Consumption and Cardiovascular Outcomes in Patients With Atrial Fibrillation; a RE-LY AF Registry Analysis. Circulation. 2022
- Mineralocorticoid Receptor Antagonists and Atrial Fibrillation: A Systematic Review and Meta-Analysis. Circulation. 2022
- A prediction model for ventricular tachycardia events using 24h ambulatory ECG. European Heart Journal. 405-405. 2022
- Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression. European Journal of Internal Medicine. 84-94. 2022
- Association of Eligibility for a Sodium-Glucose Co-Transporter 2 Inhibitor and Cardiovascular Outcomes in Patients with Atrial Fibrillation. Circulation. 2021
- Non-Pharmacological Interventions to Improve Electrical Cardioversion Success in Patients With Atrial Fibrillation: A Scoping Review. Circulation. 2021
- Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis. Europace. 1159-1166. 2019
- Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation. Canadian Journal of Cardiology. 389-395. 2019
- A Randomized Controlled Trial of Continued versus Interrupted Novel Oral Anti-Coagulant at the Time of Device Surgery (BRUISE CONTROL-2). Circulation. E450-E450. 2017
- Managing Atrial Fibrillation in the Emergency Department: Physician Experiences. International Journal of Qualitative Methods. 2017
- Safety and Efficacy of Routine Defibrillation Testing at Time of Defibrillator Implantation: A Meta-analysis of Randomized-Controlled Trials. Circulation. 2017
- PREDICTORS OF ANTICOAGULANT PRESCRIPTION IN PATIENTS WITH ATRIAL FIBRILLATION IN NORTH AMERICA: THE GLORIA-AF REGISTRY. Journal of the American College of Cardiology. 413-413. 2017
- Atrial Substrate Modification With Aggressive Blood Pressure Control to Prevent Atrial Fibrillation (SMAC AF). Circulation. E713-E714. 2016
- Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Monitor in Patients With Cardiovascular Risk Factors: ASSERT II. Circulation. E714-E714. 2016
- Risk of Stroke Associated With Atrial Fibrillation After Non-cardiac Surgery: Insights From a Meta-analysis of Randomized Controlled Studies and Observational Studies. Circulation. 2016
- Risk of Stroke Associated With Atrial Fibrillation After Non-cardiac Surgery: Insights From a Meta-analysis of Randomized Controlled Studies and Observational Studies. Circulation. 2016
- Surgical ablation of atrial fibrillation ablation in 11 countries: the LAAOS III trial. European Heart Journal. 280-280. 2016
- Patient decision aids in new implantable cardioverter defibrillator candidates: feasibility of conducting a randomized controlled trial. European Journal of Cardiovascular Nursing. S86-S86. 2016
- Association between Paroxysmal Supraventricular Tachycardia and Ischemic Stroke in Patients Without Atrial Fibrillation.. Stroke. 2016
- Early Repolarization and Implantable Cardioverter Defibrillator Events in Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation. 2015
- Sub-clinical Atrial Fibrillation in Elderly Primary Care Patients Without Clinical Atrial Fibrillation. Circulation. 2015
- Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators. Circulation. Heart Failure. 927-937. 2015
- Real world usage of direct oral anticoagulants in patients undergoing electrical cardioversion for atrial tachyarrhythmias. European Heart Journal. 391-391. 2015
- Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes: A meta-analysis. European Heart Journal. 396-396. 2015
- Troponin T or I levels following ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial. European Heart Journal. 208-208. 2015
- Bleeding and thromboembolic outcomes in warfarin-and dabigatran-treated patients in the RE-LY trial who required an urgent surgery or procedure. Journal of Thrombosis and Haemostasis. 393-394. 2015
- Can Biomarkers Improve Risk Stratification of Atrial Fibrillation Patients? Analysis of 3578 Aspirin-treated Patients in ACTIVE and AVERROES. Circulation. 2014
- Exome Chip Analysis From the CASPER Registry Highlights Potential Genetic Variant Associated With Unexplained Cardiac Arrest. Circulation. 2014
- Management of dyspepsia symptoms on dabigatran during RELY-ABLE: a long-term follow up of RE-LY patients.. Pharmacotherapy. E185-E186. 2014
- Cost effectiveness of device surgery without interruption of oral anticoagulation: results from the bridge or continue warfarin for device surgery randomized controlled trial (Bruise control). European Heart Journal. 266-266. 2014
- Additional Ablation Lines During First Redo Procedures as Predictors of Post Ablation AF Recurrence. Journal of Cardiovascular Electrophysiology. 573-574. 2014
- THE GLOBAL REGISTRY PROGRAM ON LONG-TERM ORAL ANTI-THROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILLATION (GLORIA-AF): FIRST ASSESSMENT OF BASELINE CHARACTERISTICS OF DABIGATRAN AND VKA COHORTS IN NORTH AMERICA. Journal of the American College of Cardiology. A417-A417. 2014
- Does the Degree of Left Ventricular Dysfunction or Symptom Status Influence the Risk of Stroke or Systemic Embolism Among Patients With Atrial Fibrillation and Heart Failure?-Results From the ACTIVE Study. Circulation. 2013
- Implantable Cardioverter Defibrillator Events and Mortality in Unexplained Cardiac Arrest Subjects in the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation. 2013
- Achieving Consensus About Content to Include in a Decision Aid for Implantable Defibrillator Candidates: Use of the Delphi Process. Canadian Journal of Cardiology. S369-S370. 2013
- Current Use of Oral Anticoagulants Therapy in Pacemaker Patients With Pacemaker-Detected Atrial Fibrillation: Results From a Four-Nation Physician Survey. Canadian Journal of Cardiology. S191-S191. 2013
- Echocardiographic Assessment of Tricuspid Valve Regurgitation Induced by Temporary or Permanent Leads in Patients Undergoing Ablation or Permanent Device Implantation. Canadian Journal of Cardiology. S160-S160. 2013
- IMPACT OF ADDITIONAL LEFT ATRIAL LINES ON AF RECURRENCE IN PATIENTS UNDERGOING PULMONARY VEIN ISOLATION REDO PROCEDURE. Canadian Journal of Cardiology. S181-S181. 2013
- PULMONARY VEIN DIAMETER AND POST RADIOFREQUENCY ABLATION ATRIAL FIBRILLATION RECURRENCE: DOES SIZE MATTER?. Canadian Journal of Cardiology. S181-S181. 2013
- Perioperative Management of Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Cardiac Rhythm Device Surgery: A Survey of Canadian Centers. Canadian Journal of Cardiology. S193-S194. 2013
- Predictors of Pacemaker Dependency and Heart Failure Hospitalizations in Pacemaker Patients in the Assert Trial. Canadian Journal of Cardiology. S358-S359. 2013
- Safety and Efficacy of Dabigatran Compared to Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: a Meta-Analysis. Canadian Journal of Cardiology. S100-S100. 2013
- Surgical Checklist to Reduce Pacemaker and Implantable Cardioverter-Defibrillator Lead Dislodgements. Canadian Journal of Cardiology. S360-S360. 2013
- Management of dyspepsia symptoms on dabigatran during RELY-ABLE: long-term follow up study after RE-LY. European Heart Journal. 102-102. 2013
- Comparison of Dabigatran versus Warfarin in Diabetic Patients with Atrial Fibrillation: Results from the RE-LY Trial. Circulation. 2012
- Incidence of Pacemaker-Detected Atrial Tachyarrhythmias in Elderly Patients with Hypertension and a History of Stroke or Transient Ischemic Attack. Circulation. 2012
- Population-Based Evaluation of Appropriate Therapies and Death Among Elderly Implantable Cardioverter Defibrillator (ICD) Recipients: The Ontario ICD Database. Circulation. 2012
- 066 Active Versus Passive Fixation Atrial Leads: Incidence of Atrial Tachyarrhythmias Among Patients of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT). Canadian Journal of Cardiology. S110-S111. 2012
- 440 Role of Pre-Procedural Multidetector Cardiac CT Scan in Left Ventricular Lead Placement in Cardiac Resynchronization Therapy (CRT): A Pilot Study. Canadian Journal of Cardiology. S264-S264. 2012
- 598 Multidetector Cardiac CT Scan Coronary Sinus Anatomy in Patients Undergoing CRT Device Implantation. Canadian Journal of Cardiology. S320-S320. 2012
- 766 Prevention of Arrhythmia Device Infection Trial (PADIT): Pilot Study Results. Canadian Journal of Cardiology. S394-S394. 2012
- 768 Prevalence and Predictors of Sub-Clinical Atrial Fibrillation in Pacemaker Patients. Canadian Journal of Cardiology. S394-S394. 2012
- Finding cardiac abnormalities in family members of cardiac arrest or sudden death victims through comprehensive clinical and genetic screening: results from the CASPER registry. European Heart Journal. 972-972. 2012
- Evolution of Clinical Diagnosis in Patients Presenting with Unexplained Cardiac Arrest. Circulation. 2011
- Global Variation in the Etiology and Management of Atrial Fibrillation: Results from a Global Atrial Fibrillation Registry. Circulation. 2011
- Left Ventricular Lead Position and Long-Term Clinical Outcome in the RAFT Trial. Circulation. 2011
- PCV50 Hospital Costs Associated with Atrial Fibrillation in Canada. Value in Health. A373-A373. 2011
- Specificity of atrial high-rate episodes at different rates and durations: an analysis from the ASSERT trial. Acta Cardiologica. 681-682. 2011
- 445 Discovering heart disease in first degree relatives of sudden death victims: A preliminary report from the casper registry. Canadian Journal of Cardiology. S223-S224. 2011
- 447 Role of adrenaline infusion in evaluation of patients with unexplained cardiac arrest and familial sudden death. Canadian Journal of Cardiology. S224-S225. 2011
- 500 Left ventricular lead position in raft - evaluating the agreement between implant and blinded post-operative chest radiograph categorization. Canadian Journal of Cardiology. S243-S243. 2011
- 504 Does cardiac resynchronization therapy improve outcomes in patients with chronic atrial tachyarrhythmias? results from the resynchronization for ambulatory heart failure trial (raft). Canadian Journal of Cardiology. S245-S245. 2011
- 638 Outcomes of primary prevention implantable cardioverter defibrillator (ICD) recipients with vs without clinical trial entry criteria: Observations from a comprehensive provincial ICD registry. Canadian Journal of Cardiology. S294-S294. 2011
- 642 Failed defibrillation testing among patients having ICD replacement: Incidence, predictors and influence of selection BIAS. Canadian Journal of Cardiology. S296-S297. 2011
- 901 Does cardiac resynchronization therapy improve outcomes in patients with chronic atrial tachyarrhythmias? Results from the resynchronization for ambulatory heart failure trial (RAFT). Canadian Journal of Cardiology. S334-S335. 2011
- Differences in baseline electrophysiologic properties and electrical remodeling among pacemaker patients who develop atrial tachyarrhythmias: results of the ASSERT mechanisms of atrial fibrillation St. European Heart Journal. 930-930. 2011
- Predictors of atrio-ventricular conduction disease, long term outcomes and a strategy to prevent sudden cardiac death in patients with myotonic dystrophy types 1 and 2. European Heart Journal. 16-17. 2011
- Cardiac Resynchronization Therapy in Patients With RBBB in the Ontario ICD Registry; Assessment of Contemporary Practice and Outcomes. Circulation. 2010
- Derivation and Validation of a Simple Exercise-Based Algorithm for Prediction of Genetic Testing in Relatives of LQTS Probands. Circulation. 2010
- Effect of Coronary Ischemic Burden on Therapies for Ventricular Tachyarrhythmia (VT) and Death in Patients with an Implantable Cardioverter Defibrillator (ICD). Circulation. 2010
- Sentinel Symptoms in Patients with Unexplained Cardiac Arrest from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Circulation. 2010
- The Relationship Between Atrial High-Rate Episodes and Stroke: The Asymptomatic Stroke and Atrial Fibrillation Evaluation in Pacemaker Patients (ASSERT) Trial. Circulation. 2220-2221. 2010
- The Resynchronization/Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circulation. 2216-2216. 2010
- INCIDENCE AND PREDICTORS OF STROKE FOLLOWING CARDIAC SURGERY: THE IMPACT OF ATRIAL FIBRILLATION. Canadian Journal of Cardiology. 109D-109D. 2010
- PREVENTION OF ARRHYTHMIA DEVICE INFECTION TRIAL (PADIT): EVIDENCE OF EQUIPOISE. Canadian Journal of Cardiology. 132D-132D. 2010
- RISK OF COMPLICATIONS AMONG ELDERLY RECIPIENTS OF PERMANENT PACEMAKERS. Canadian Journal of Cardiology. 90D-90D. 2010
- EFFECT OF AGE AND RENAL FUNCTION ON THE RISKS OF STROKE AND MAJOR BLEEDING WITH DABIGATRAN COMPARED TO WARFARIN: AN ANALYSIS FROM THE RE-LY STUDY. Journal of the American College of Cardiology. 2010
- Complications Increase Mortality Risk After De Novo Implantion of a Cardioverter Defibrillator: Initial Findings From the Ontario ICD Database. Circulation. S637-S638. 2009
- EFFECTS OF STATIN ON MORTALITY AND APPROPRIATE SHOCKS IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR PATIENTS: A SYSTEMATIC REVIEW OF COHORT STUDIES. Journal of Cardiovascular Electrophysiology. S18-S19. 2009
- Lead dislodgement and lead related cardiac perforation in ICD patients. European Heart Journal. 309-309. 2009
- Management of atrial fibrillation in the emergency department: are we adhering to guidelines?. European Heart Journal. 819-819. 2009
- Wide area circumferential ablation for pulmonary vein isolation in patients with atrial fibrillation and pulmonary vein stenosis. European Heart Journal. 414-414. 2009
- Anticoagulation of Patients on Chronic Warfarin Undergoing Arrhythmia Device Surgery: Wide Variability of Perioperative Bridging in Canada. Circulation. S595-S596. 2008
- CASPER: Study Design and Preliminary Results in Probands from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry. Circulation. S927-S927. 2008
- Impact of Alerts on Outcome of the Fidelis Implantable Cardioverter-Defibrillator Lead Advisory: A Report from the Canadian Heart Rhythm Society Device Advisories Committee. Circulation. S927-S927. 2008
- Impact of ramipril on the development of prolonged QT interval: results of the Heart Outcomes Prevention Evaluation (HOPE) study. European Heart Journal. 604-604. 2008
- Comparison of right ventricular strain and strain rate in patients with Arrhythmogenic right ventricular cardiomyopathy, right ventricular outflow tract tachycardia, and matched controls. Circulation. 424-424. 2007
- A systematic review of randomized trials comparing catheter-based radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. Canadian Journal of Cardiology. 148C-148C. 2007
- Comparison of RV strain and strain rate in patients with arrhythmogenic RV cardiomyopathy, RV outflow tract tachycardia, and matched controls. Canadian Journal of Cardiology. 176C-177C. 2007
- Development of an improved strategy for perioperative bridging of anticoagulation: Predictors of wound hematoma following surgery for permanent pacemakers and implantable defibrillators. Canadian Journal of Cardiology. 174C-174C. 2007
- Device-related infections among patients with pacemakers and implantable defibrillators: Incidence, risk factors and consequences. Canadian Journal of Cardiology. 174C-175C. 2007
- Does left atrial size remodelling predict recurrence of atrial fibrillation after circumferential pulmonary vein isolation?. Journal of Cardiovascular Electrophysiology. S80-S81. 2007
- Effects of forced ventricular pacing in patients undergoing atrioventricular node ablation for ventricular rate control in patients with atrial fibrillation. Canadian Journal of Cardiology. 64C-64C. 2007
- LV systolic and diastolic function in patients with arrhythmogenic right ventricular cardiomyopathy. Canadian Journal of Cardiology. 237C-238C. 2007
- 763 The use of independently programmable configurations to optimize sensing and pacing and to decrease re-operation rates in CRT patients. European Journal of Heart Failure, Supplement. 173-173. 2007
- Aspirin and the Risk of Heart Failure Hospitalization in Patients with Atrial Fibrillation and a Prior History of Heart Failure: An ACTIVE-W Analysis. Journal of Cardiac Failure. 762-762. 2006
- Impact of vascular events on mortality in AF patients: Insights from ACTIVE W. Circulation. 790-791. 2006
- Neither ramipril nor vitamin E reduces the incidence of atrial fibrillation. Results of the HOPE study.. Circulation. 745-746. 2006
- Does left atrial scarring determine success in patients undergoing pulmonary vein isolation for atrial fibrillation?. European Heart Journal. 42-42. 2006
- Effect of underlying risk of stroke on treatment effects in the ACTIVE-W Trial. European Heart Journal. 35-36. 2006
- Will implementing a syncope assessment algorithm at emergency room reduce hospital admissions and health care costs?. European Heart Journal. 378-378. 2006
- The management of hypertension in patients with atrial fibrillation: Impact of specialist care. Ethnicity and Disease. S47-S47. 2006
- Neither Ramipril nor Vitamin E reduce the incidence of atrial fibrillation. Results of the HOPE study. Journal of the American College of Cardiology. 8A-9A. 2006
- Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analysis. Circulation. 461-461. 2004
- Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. American Journal of Cardiology. 9-14. 2003
- Prospective randomized study of conventional vs. irrigated radiofrequency ablation of atrial fibrillation: A pilot study. Circulation. 670-670. 2002
- Prognostic use of cardiac troponin T and troponin I in patients with heart failure.. Clinical Chemistry. A197-A197. 2001
- Prognostic value of serum troponin T and troponin I in heart failure. Circulation. 780-780. 2000
journal articles
- Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial. European Journal of General Practice. 30:2327367. 2024
- Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.. European Heart Journal. 45:4902-4916. 2024
- Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.. Circulation. 150:1747-1755. 2024
- Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trial.. European Journal of Heart Failure. 2024
- Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.. New England Journal of Medicine. 2024
- Left Atrial Appendage Closure after Ablation for Atrial Fibrillation.. New England Journal of Medicine. 2024
- Temporal Trends in the Management Practices of Clinically Important Perioperative Atrial Fibrillation After Noncardiac Surgery.. CJC OPEN. 6:1363-1371. 2024
- Mineralocorticoid receptor antagonists for atrial fibrillation prevention: effective solution or empty promise?. European Heart Journal. ehae687. 2024
- In memoriam: Stuart J. Connolly, MD (9 April 1949-2 June 2024).. European Heart Journal. 45:ehae668. 2024
- Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AF.. Journal of the American College of Cardiology. 84:1528-1540. 2024
- Response by McIntyre et al to Letter Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials".. Circulation. 150:e274-e275. 2024
- Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.. Journal of the American Heart Association. 13:e034758. 2024
- Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trial.. European Stroke Journal. 23969873241276358. 2024
- A Systematic Review of Ongoing Registered Research Studies on Post-Operative Atrial Fibrillation after Cardiac Surgery.. Journal of Clinical Medicine. 13:4948. 2024
- Apixaban vs rivaroxaban in patients with atrial fibrillation at high or low bleeding risk: A population-based cohort study.. Heart Rhythm. S1547-5271(24)03151-5. 2024
- Diagnostic reliability of monitoring for premature atrial and ventricular complexes. Europace. 26:euae198. 2024
- A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial. American Heart Journal. 274:1-10. 2024
- Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit. European Heart Journal, Supplement. 26:iv4-iv11. 2024
- Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study. Circulation: Arrhythmia and Electrophysiology. 17:e012764. 2024
- High-Risk Nonclassical Long-QT Syndrome Genotypes: Spectrum of Genetic and Phenotypic Features. Circulation. Genomic and precision medicine. 17:e004554. 2024
- Stuart J. Connolly, MD, April 9, 1949–June 2, 2024. Heart Rhythm. 21:1456-1457. 2024
- A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome. Journal of the American Medical Association (JAMA). 332:204-204. 2024
- Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry. European Heart Journal. 45:2336-2340. 2024
- Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation. Journal of the American College of Cardiology. 84:354-364. 2024
- Effects of Implantable Cardioverter-Defibrillator Leads on the Tricuspid Valve and Right Ventricle. JACC: Clinical Electrophysiology. 10:2088-2096. 2024
- Histidine-Rich Glycoprotein Modulates the Toxic Effects of High-Dose Polyphosphate in Mice. Arteriosclerosis, Thrombosis and Vascular Biology. 44:1658-1670. 2024
- Is Investigator Sex Associated With Female Underenrollment in Arrhythmia Trials?. JACC: Clinical Electrophysiology. 10:1486-1488. 2024
- Landiolol for perioperative atrial tachyarrhythmias in cardiac and thoracic surgery patients: a systematic review and meta-analysis. British Journal of Anaesthesia. 133:222-225. 2024
- Retraction notice to: PO-0437 ARTIFICIAL INTELLIGENCE FOR ANALYSIS OF MOBILE CARDIAC TELEMETRY. Heart Rhythm. 21:S1547-5271(24)02835-2. 2024
- Sodium Intake and Incident Atrial Fibrillation in Individuals With Vascular Disease. JAMA network open. 7:e2421589-e2421589. 2024
- Stuart J. Connolly, MD, April 9, 1949–June 2, 2024. JACC: Clinical Electrophysiology. S2405-500X(24)00562-0. 2024
- Peri‐mortem arrhythmias in the non‐cardiac intensive care unit. Nursing in Critical Care. 2024
- Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction. JAMA cardiology. 9:545-545. 2024
- Conduction system pacing versus biventricular pacing in heart failure with reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 21:881-889. 2024
- Recurrence of new-onset post-operative AF after cardiac surgery: detected by implantable loop recorders: A systematic review and Meta-analysis. International Journal of Cardiology. 404:131930-131930. 2024
- Reference ranges for ambulatory heart rate measurements in a middle-aged population. Heart. 110:831-837. 2024
- Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC. European Heart Journal. 45:1701-1715. 2024
- Device-specific quality of life: results from the ATLAS trial—avoid transvenous leads in appropriate subjects. European Journal of Cardiovascular Nursing. zvae067. 2024
- RETRACTED: PO-04-037 ARTIFICIAL INTELLIGENCE FOR ANALYSIS OF MOBILE CARDIAC TELEMETRY. Heart Rhythm. 21:S467-S468. 2024
- When to prescribe oral anticoagulation for patients with device-detected subclinical atrial fibrillation? Insights from the NOAH-AFNET 6 and ARTESiA trials. European Journal of Internal Medicine. 123:52-54. 2024
- Stroke Prevention in Subclinical Atrial Fibrillation. New England Journal of Medicine. 390:1441-1442. 2024
- What Should You Do When You Find Atrial Fibrillation on an Implanted Pacemaker or Defibrillator? It’s More Than You Think…. Canadian Journal of Cardiology. 40:608-609. 2024
- Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference. Europace. 26:euae070. 2024
- Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Circulation. 149:981-988. 2024
- Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials. European Heart Journal. 45:756-774. 2024
- Straining the Limits: Atrial Imaging to Predict Subclinical Atrial Fibrillation. Circulation. Cardiovascular Imaging. 17:e016412. 2024
- Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy. Journal of the American Medical Association (JAMA). 331:573-573. 2024
- Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe. European Heart Journal. 45:538-548. 2024
- Long-Term Outcomes of Resynchronization–Defibrillation for Heart Failure. New England Journal of Medicine. 390:212-220. 2024
- Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation. New England Journal of Medicine. 390:107-117. 2024
- Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A Randomized, Placebo-Controlled Trial. Circulation: Arrhythmia and Electrophysiology. 17:e01238. 2024
- Risk of stroke with reduced dose direct oral anticoagulants vs standard dose anticoagulation after cardioversion of atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm O2. 2024
- Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Lancet Neurology. 22:1140-1149. 2023
- Risk Scores for Prediction of Postoperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-Analysis. American Journal of Cardiology. 209:232-240. 2023
- The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest. JACC: Clinical Electrophysiology. 9:2494-2503. 2023
- Can 24 h of ambulatory ECG be used to triage patients to extended monitoring?. Annals of Noninvasive Electrocardiology. 28:e13090. 2023
- Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial. The Lancet. 402:1627-1635. 2023
- Landiolol for the prevention of postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. Canadian Journal of Anaesthesia. 70:1828-1838. 2023
- Markers of Atrial Myopathy in the General Population. JACC: Clinical Electrophysiology. 9:2240-2249. 2023
- Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III. Circulation. 148:1298-1304. 2023
- Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness. ACP journal club. 176:1299-1307. 2023
- Health Security Perceptions: Initial Psychometric Analysis of the Construct of Health Security in Chronic Illness Among Patients With a Cardiac Device. CJC OPEN. 5:704-708. 2023
- Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies. JACC: CardioOncology. 5:415-430. 2023
- Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch Block. CJC OPEN. 5:611-618. 2023
- Ventricular tachycardia risk prediction with an abbreviated duration mobile cardiac telemetry. Heart Rhythm O2. 4:500-505. 2023
- Rhythm vs. Rate Control in Patients with Postoperative Atrial Fibrillation after Cardiac Surgery: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 12:4534-4534. 2023
- Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial. The Lancet. 402:118-128. 2023
- Ventricular Tachycardia and ICD Therapy Burden With Catheter Ablation Versus Escalated Antiarrhythmic Drug Therapy. JACC: Clinical Electrophysiology. 9:808-821. 2023
- Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality. JAMA cardiology. 8:484-484. 2023
- Identification and in-silico characterization of splice-site variants from a large cardiogenetic national registry. European Journal of Human Genetics. 31:512-520. 2023
- Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial. American Heart Journal. 259:87-96. 2023
- Anticoagulation use in perioperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis. Swiss Medical Weekly. 153:40056-40056. 2023
- Management of Inherited Arrhythmia Syndromes: A HiRO Consensus Handbook on Process of Care. CJC OPEN. 5:268-284. 2023
- Alcohol Consumption and Atrial Arrhythmia Recurrence After Atrial Fibrillation Ablation: A Systematic Review and Meta-analysis. Canadian Journal of Cardiology. 39:266-273. 2023
- Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke: comment—Authors’ reply. Europace. 25:778-778. 2023
- Techniques improving electrical cardioversion success for patients with atrial fibrillation: a systematic review and meta-analysis. Europace. 25:318-330. 2023
- Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference. Europace. 25:6-27. 2023
- Embolic Stroke of Undetermined Source: Current Perspectives on Diagnosis, Investigations, and Management. Canadian Journal of Cardiology. 39:172-186. 2023
- Incremental value of the signal-averaged ECG for diagnosing arrhythmogenic cardiomyopathy. Heart Rhythm. 20:224-230. 2023
- Perceived self-efficacy and empowerment in patients at increased risk of sudden cardiac arrest. Frontiers in Cardiovascular Medicine. 10:955060. 2023
- Advances in Cardiac Electrophysiology. Circulation: Arrhythmia and Electrophysiology. 15:e009911. 2022
- Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations. ACP journal club. 175:1658-1665. 2022
- Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration. Circulation. 146:1461-1474. 2022
- Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis. Europace. 24:1548-1559. 2022
- Remote ECG monitoring to reduce complications following transcatheter aortic valve implantations: the Redirect TAVI study. Europace. 24:1475-1483. 2022
- Sex differences in presentation of atrial fibrillation: Findings from 30-day ambulatory monitoring in real-world practice. Am Heart J Plus. 22:100208-100208. 2022
- Use of Anticoagulation Therapy in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-analysis. CJC OPEN. 4:840-847. 2022
- Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials. European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy. 8:648-659. 2022
- Sex Differences and Utility of Treadmill Testing in Long‐QT Syndrome. Journal of the American Heart Association. 11:e025108. 2022
- Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial Fibrillation. Canadian Journal of Cardiology. 38:1434-1441. 2022
- Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial. American Heart Journal. 251:35-42. 2022
- Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator. European Heart Journal. 43:3041-3052. 2022
- Importance of genetic testing in unexplained cardiac arrest. European Heart Journal. 43:3071-3081. 2022
- A clinical dilemma: the longer the higher the risk?—Authors’ reply. Europace. 24:1196-1197. 2022
- Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke. Europace. 24:1058-1064. 2022
- Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial. Europace. 24:1112-1118. 2022
- Screening for atrial fibrillation to prevent stroke: a meta-analysis. European Heart Journal Open. 2:oeac044. 2022
- Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial. Circulation. 145:1693-1704. 2022
- OCEAN trial update. American Heart Journal. 248:169-169. 2022
- In Memoriam: George Wyse (1941-2022). Canadian Journal of Cardiology. 38:412-413. 2022
- Return of Results Policies for Genomic Research: Current Practices and the Hearts in Rhythm Organization (HiRO) Approach. Canadian Journal of Cardiology. 38:526-535. 2022
- New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 15:603-613. 2022
- Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration. Circulation. 145:392-409. 2022
- Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial. Heart Rhythm O2. 3:40-49. 2022
- Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS ₂ Score: Insights From the BRAIN-AF Trial. Circulation: Arrhythmia and Electrophysiology. 15:e010462. 2022
- Prospective long-term follow-up of silicone-polyurethane–insulated implantable cardioverter-defibrillator leads. Heart Rhythm O2. 3:57-64. 2022
- Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status. JACC: Clinical Electrophysiology. 8:182-193. 2022
- Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease. Cardiovascular Research (CVR). 118:295-304. 2022
- Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis. Journal of Thrombosis and Thrombolysis. 53:74-82. 2022
- SGLT2 Inhibitors: A Game-Changer for Patients with Atrial Fibrillation?. Journal of Atrial Fibrillation. 15:53-54. 2022
- Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis. CJC OPEN. 4:85-96. 2022
- Assessment of Radiation-Induced Malfunction in Cardiac Implantable Electronic Devices. CJC OPEN. 3:1438-1443. 2021
- Incidence and Predictors of Heart Failure in Patients With Atrial Fibrillation. CJC OPEN. 3:1482-1489. 2021
- The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial. BMC Cardiovascular Disorders. 21:445. 2021
- Canadian Heart Rhythm Society Task Force Report on Physician Training and Maintenance of Competency for Cardiovascular Implantable Electronic Device Therapies: Executive Summary. Canadian Journal of Cardiology. 37:1857-1860. 2021
- Sex-Specific Clinical Outcomes of the PACT-HF Randomized Trial. Circulation. Heart Failure. 14:e008548. 2021
- Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. European Journal of Internal Medicine. 92:100-106. 2021
- LVS‐HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World‐Wide Registry. Journal of the American Heart Association. 10:e017735. 2021
- Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Journal of the American Heart Association. 10:e022222. 2021
- Reply. Journal of the American College of Cardiology. 78:e91-e92. 2021
- Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials. Europace. 23:1200-1210. 2021
- Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype. Circulation: Arrhythmia and Electrophysiology. 14:e009591. 2021
- Systematic review of treatment gaps in oral anticoagulant use in atrial fibrillation. Thrombosis Update. 4:100053-100053. 2021
- Short-coupled ventricular fibrillation represents a distinct phenotype among latent causes of unexplained cardiac arrest: a report from the CASPER registry. European Heart Journal. 42:2827-2838. 2021
- Antidiabetic drugs for preventing atrial fibrillation: A new revolution?. Heart Rhythm. 18:1097-1097. 2021
- Detection of atrial fibrillation in asymptomatic at-risk individuals. International Journal of Cardiology. 334:55-57. 2021
- Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysis. Canadian Journal of Anaesthesia. 68:1045-1056. 2021
- New‐Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Risk of Adverse Events: An Analysis From the CORONARY Trial. Journal of the American Heart Association. 10:e020426. 2021
- Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. New England Journal of Medicine. 384:2081-2091. 2021
- Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation. Journal of the American College of Cardiology. 77:2875-2886. 2021
- Variant Reinterpretation in Survivors of Cardiac Arrest With Preserved Ejection Fraction (the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry) by Clinicians and Clinical Commercial Laboratories. Circulation. Genomic and precision medicine. 14:e003235. 2021
- World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update. Global Heart. 16:41. 2021
- Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals. Cardiovascular Research (CVR). 117:1523-1531. 2021
- Post-operative pain following cardiac implantable electronic device implantation: insights from the BRUISE CONTROL trials. Europace. 23:748-756. 2021
- Association Between Perioperative Atrial Fibrillation and Long-term Risks of Stroke and Death in Noncardiac Surgery: Systematic Review and Meta-analysis. CJC OPEN. 3:666-674. 2021
- Device-Detected Atrial Fibrillation Before and After Hospitalisation for Noncardiac Surgery or Medical Illness: Insights From ASSERT. Canadian Journal of Cardiology. 37:803-809. 2021
- Screening for Atrial Fibrillation in the Older Population. JAMA cardiology. 6:558-558. 2021
- A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design. American Heart Journal. 234:90-100. 2021
- Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES. Thrombosis and Haemostasis. 121:518-528. 2021
- The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape. Canadian Journal of Cardiology. 37:644-654. 2021
- Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. Europace. 23:329-344. 2021
- Is Screening for Atrial Fibrillation and Its Risk Factors Useful and Cost-Effective?. Cardiac Electrophysiology Clinics. 13:235-241. 2021
- Outcomes and Safety of Fluoroless Catheter Ablation for Atrial Fibrillation. CJC OPEN. 3:303-310. 2021
- Research Priorities in Atrial Fibrillation Screening. Circulation. 143:372-388. 2021
- Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter‐Based Atrial Fibrillation Ablation: A Population‐Based Cohort Study From Ontario, Canada. Journal of the American Heart Association. 10:e016071. 2021
- High-Sensitivity Estimate of the Incidence of New-Onset Atrial Fibrillation in Critically Ill Patients. Critical Care Explorations. 3:e0311-e0311. 2021
- Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study. CMAJ open. 9:E53-E61. 2021
- Stroke Prevention in Atrial Fibrillation. Circulation. 142:2371-2388. 2020
- Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation. Heart. 106:1847-1852. 2020
- Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration. European Journal of Internal Medicine. 82:97-104. 2020
- The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Canadian Journal of Cardiology. 36:1847-1948. 2020
- Continued versus interrupted direct oral anticoagulation for cardiac electronic device implantation: A systematic review. PACE - Pacing and Clinical Electrophysiology. 43:1373-1381. 2020
- The Hearts in Rhythm Organization: A Canadian National Cardiogenetics Network. CJC OPEN. 2:652-662. 2020
- Clinical outcomes in patients with systolic heart failure. Are atrial high rate episodes a common marker of disease progression?. International Journal of Cardiology. 316:184-185. 2020
- New Onset Atrial Fibrillation Following Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Heart Lung and Circulation. 29:1542-1553. 2020
- An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation. 142:932-947. 2020
- Active-Fixation Atrial Leads and the Risk of Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 13:e008655. 2020
- Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes. Journal of the American Heart Association. 9:e017086. 2020
- Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial. CJC OPEN. 2:354-359. 2020
- Remote Ambulatory Cardiac Monitoring Before and After Transcatheter Aortic Valve Replacement. CJC OPEN. 2:416-419. 2020
- Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Catheter Ablation or Antiarrhythmic Drug Therapy: A Systematic Review and Meta-analysis. CJC OPEN. 2:286-295. 2020
- Population-Based Screening for Atrial Fibrillation. Circulation Research. 127:143-154. 2020
- Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction. Journal of the American Heart Association. 9:e013227. 2020
- Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis. Europace. 22:870-877. 2020
- Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society. Canadian Journal of Cardiology. 36:948-951. 2020
- Impact of Cardiac Implantable Electronic Device Infection. Circulation: Arrhythmia and Electrophysiology. 13:e008280. 2020
- Atrial fibrillation and stroke: chicken or egg? Does it really matter?. Europace. 22:509-510. 2020
- Modifiable risk factors predict incident atrial fibrillation and heart failure. Open Heart. 7:e001092-e001092. 2020
- Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen?. Canadian Journal of Cardiology. 36:459-461. 2020
- Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group. European Heart Journal. 41:1132-1140. 2020
- Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source. Stroke. 51:938-943. 2020
- Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators. JACC: Clinical Electrophysiology. 6:327-337. 2020
- Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?. Current Opinion in Neurology. 33:17-23. 2020
- Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme. Europace. 22:47-57. 2020
- Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study. PLoS ONE. 15:e0226259-e0226259. 2020
- Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment—Reply. JAMA Neurology. 77:134-134. 2020
- Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery. Circulation: Arrhythmia and Electrophysiology. 13:e007437. 2020
- Prevalence of undiagnosed atrial fibrillation in elderly individuals and potential cost-effectiveness of non-invasive ambulatory electrocardiographic screening: The ASSERT-III study. Journal of Electrocardiology. 58:56-60. 2020
- Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group. International Journal of Cardiology. 296:65-70. 2019
- Searching for Atrial Fibrillation Poststroke. Circulation. 140:1834-1850. 2019
- Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) incidence study. Journal of Electrocardiology. 57:95-99. 2019
- Pre-Screening for Atrial Fibrillation Using the Electronic Health Record. JACC: Clinical Electrophysiology. 5:1342-1343. 2019
- Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma. Circulation: Arrhythmia and Electrophysiology. 12:e007545. 2019
- Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials. European Heart Journal. 40:3026-3032. 2019
- Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals. PLoS Medicine. 16:e1002903-e1002903. 2019
- Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design. Canadian Journal of Cardiology. 35:1069-1077. 2019
- Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial. International Journal of Cardiology. 288:87-93. 2019
- Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy. Journal of Clinical Investigation. 129:3171-3184. 2019
- Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population. JACC: Heart Failure. 7:586-598. 2019
- Effectiveness of single‐ vs dual‐coil implantable defibrillator leads: An observational analysis from the SIMPLE study. Journal of Cardiovascular Electrophysiology. 30:1078-1085. 2019
- Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial. Europace. 21:1023-1030. 2019
- Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation. JAMA Neurology. 76:764-764. 2019
- Screening for Atrial Fibrillation Using a Mobile, Single-Lead Electrocardiogram in Canadian Primary Care Clinics. Canadian Journal of Cardiology. 35:840-845. 2019
- Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis. Journal of the American College of Cardiology. 21:856-863. 2019
- Clinical Outcomes in Atrial Fibrillation Research. JACC: Clinical Electrophysiology. 5:606-607. 2019
- The RACE to Treat Atrial Fibrillation in the Emergency Department. New England Journal of Medicine. 380:1578-1579. 2019
- Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome. JACC: Clinical Electrophysiology. 5:504-512. 2019
- Phospholamban cardiomyopathy: a Canadian perspective on a unique population. Netherlands Heart Journal. 27:208-213. 2019
- Stroke prevention in atrial fibrillation: Closing the gap. American Heart Journal. 210:29-38. 2019
- The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED). Annals of Emergency Medicine. 73:382-392. 2019
- A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation. Journal of the American College of Cardiology. 73:1105-1105. 2019
- Atrial fibrillation detected initially during acute medical illness: A systematic review. European Heart Journal: Acute Cardiovascular Care. 8:130-141. 2019
- Challenge and Impact of Quinidine Access in Sudden Death Syndromes. JACC: Clinical Electrophysiology. 5:376-382. 2019
- Perspective and practice of surgical atrial fibrillation ablation: an international survey of cardiac surgeons. Europace. 21:445-450. 2019
- Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden. Europace. 21:377-382. 2019
- Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey. Canadian Journal of Kidney Health and Disease. 6:205435811882194-205435811882194. 2019
- Defibrillation testing and clinical outcomes after implantable cardioverter–defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial. Heart Rhythm. 16:83-90. 2019
- Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects. American Heart Journal. 207:1-9. 2019
- Sensitivity and specificity of chest imaging for sarcoidosis screening in patients with cardiac presentations.. Sarcoidosis Vasculitis and Diffuse Lung Diseases. 36:18-24. 2019
- Descriptive analysis of pharmacy services provided after community pharmacy screening. International Journal of Clinical Pharmacy. 40:1577-1586. 2018
- Prevention of venous thrombosis after electrophysiology procedures: a survey of national practice. Journal of Interventional Cardiac Electrophysiology. 53:357-363. 2018
- An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis. European Heart Journal. 39:3932-3944. 2018
- Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). European Heart Journal. 39:3973-3979. 2018
- 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. Canadian Journal of Cardiology. 34:1371-1392. 2018
- Early Repolarization Pattern Inheritance in the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). JACC: Clinical Electrophysiology. 4:1473-1479. 2018
- Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?. Canadian Journal of Cardiology. 34:1522-1525. 2018
- Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study. Europace. 20:1798-1803. 2018
- The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations. Canadian Journal of Cardiology. 34:1412-1425. 2018
- Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation. International Journal of Cardiology. 269:145-151. 2018
- Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) follow‐up cohort study. Clinical Cardiology. 41:1273-1280. 2018
- Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta‐analysis. Journal of Arrhythmia. 34:478-484. 2018
- Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients. Journal of Interventional Cardiac Electrophysiology. 53:123-129. 2018
- Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis. Cardiovascular Research (CVR). 114:1435-1444. 2018
- Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. Europace. 20:f240-f248. 2018
- Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Europace. 20:1442-1450. 2018
- Screening for undiagnosed atrial fibrillation. Expert Review of Cardiovascular Therapy. 16:591-598. 2018
- Diagnostic accuracy and yield of screening tests for atrial fibrillation in the family practice setting: a multicentre cohort study. CMAJ open. 6:E308-E315. 2018
- Stroke Prevention in Atrial Fibrillation. Journal of the American College of Cardiology. 72:154-155. 2018
- Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT). American Heart Journal. 201:160-163. 2018
- Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of High-Voltage Leads. Canadian Journal of Cardiology. 34:808-811. 2018
- Incident Atrial Fibrillation and Stroke in Patients With Atrial Flutter. Canadian Journal of Cardiology. 34:696-697. 2018
- Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure. Journal of the American College of Cardiology. 71:2603-2611. 2018
- Stroke‐prevention strategies in North American patients with atrial fibrillation: The GLORIA‐AF registry program. Clinical Cardiology. 41:744-751. 2018
- Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock. Journal of the American Medical Association (JAMA). 319:1889-1889. 2018
- A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial. American Heart Journal. 199:51-58. 2018
- Are there increased periprocedural complications with the MRI-conditional Medtronic Revo SureScan Pacing System?. Netherlands Heart Journal. 26:233-239. 2018
- Colchicine for Prevention of Perioperative Atrial Fibrillation in patients undergoing lung resection surgery: a pilot randomized controlled study. European Journal of Cardio-thoracic Surgery. 53:945-951. 2018
- Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy. JACC: Clinical Electrophysiology. 4:660-668. 2018
- Late Stroke After Coronary Artery Bypass Grafting. JAMA cardiology. 3:425-425. 2018
- Canadian Registry of Implantable Electronic Device Outcomes: Longer-term follow-up of the Riata lead under advisory. Heart Rhythm. 15:524-529. 2018
- Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing. Circulation: Arrhythmia and Electrophysiology. 11:e005921. 2018
- Limitations of Administrative Data for Examining Secondary Atrial Fibrillation. JACC: Clinical Electrophysiology. 4:561-562. 2018
- Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy. American Journal of Cardiology. 121:975-980. 2018
- Mexiletine or catheter ablation after amiodarone failure in the VANISH trial. Journal of Cardiovascular Electrophysiology. 29:603-608. 2018
- Implantable cardioverter–defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy. Heart Rhythm. 15:386-392. 2018
- Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH. Journal of Cardiovascular Electrophysiology. 29:421-434. 2018
- ST segment depression on 24-hour electrocardiography predicts incident atrial fibrillation in two population-based cohorts. Europace. 20:429-434. 2018
- Subclinical atrial fibrillation: The significance of progression to longer episodes. Heart Rhythm. 15:384-385. 2018
- The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial. American Heart Journal. 197:124-132. 2018
- The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation. European Heart Journal. 39:474-476. 2018
- Atrial fibrillation occurring transiently with stress. Current Opinion in Cardiology. 33:58-65. 2018
- Evaluating the potential for pharmacists to prescribe oral anticoagulants for atrial fibrillation. Canadian Pharmacists Journal. 151:51-61. 2018
- Evaluating the feasibility of conducting a trial using a patient decision aid in implantable cardioverter defibrillator candidates: a randomized controlled feasibility trial. Pilot and Feasibility Studies. 3:49. 2017
- Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nature Reviews Cardiology. 14:701-714. 2017
- Unconventional warfare: Successful ablation of ventricular tachycardia by direct ventricular puncture in a patient with double mechanical heart valves. HeartRhythm Case Reports. 3:599-603. 2017
- Early Life Risk Factors for Incident Atrial Fibrillation in the Helsinki Birth Cohort Study. Journal of the American Heart Association. 6:e006036. 2017
- Subclinical Atrial Fibrillation in Older Patients. Circulation. 136:1276-1283. 2017
- COST EFFECTIVENESS OF VENTRICULAR TACHYCARDIA ABLATION VERSUS ESCALATION OF ANTIARRHYTHMIC DRUG THERAPY IN THE VANISH TRIAL. Canadian Journal of Cardiology. 33:S16-S17. 2017
- Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial. Europace. 19:1630-1636. 2017
- The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients. Journal of Interventional Cardiac Electrophysiology. 50:57-63. 2017
- What Do Implanted Cardiac Monitors Reveal About Atrial Fibrillation?. JAMA cardiology. 2:1128-1128. 2017
- Response by Parkash et al to Letters Regarding Article, “Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])”. Circulation. 136:1271-1272. 2017
- Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 19:1556-1578. 2017
- Genetic Testing in the Evaluation of Unexplained Cardiac Arrest From the CASPER (Cardiac Arrest Survivors With Preserved Ejection Fraction Registry). Circulation. 136:872-872. 2017
- Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation. CMAJ open. 5:E653-E661. 2017
- Comparison of health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis protocol. BMJ Open. 7:e017577-e017577. 2017
- Loss-of-Function KCNE2 Variants. Circulation: Arrhythmia and Electrophysiology. 10:e005282. 2017
- Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. American Heart Journal. 189:137-145. 2017
- The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome. JACC: Clinical Electrophysiology. 3:727-743. 2017
- Cardiac implantable electronic device infections: From recognizing risk to prevention. Heart Rhythm. 14:846-847. 2017
- Genetic Testing in the Evaluation of Unexplained Cardiac Arrest. Circulation. Genomic and precision medicine. 10:e001686. 2017
- Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial. Europace. 19:euw116-euw116. 2017
- Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation. Circulation. 135:1788-1798. 2017
- Screening for Atrial Fibrillation. Circulation. 135:1851-1867. 2017
- Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. European Heart Journal. 38:1339-1344. 2017
- Harder Roads to Trek? Paradoxical Slowing of an Atrioventricular Reentrant Tachycardia With Contralateral Bundle Branch Block. Journal of Cardiovascular Electrophysiology. 28:455-457. 2017
- Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients. Circulation: Arrhythmia and Electrophysiology. 10:e004875. 2017
- Risk of mortality and stroke after atrial fibrillation – Authors' reply. The Lancet. 389:907-907. 2017
- The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation. JAMA cardiology. 2:324-324. 2017
- The left atrium: An overlooked prognostic tool. European Journal of Preventive Cardiology (EJPC). 24:389-391. 2017
- Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study (vol 388, pg 1161, 2016). The Lancet. 389:602-602. 2017
- Cardioembolic Stroke. Circulation Research. 120:514-526. 2017
- Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis. Europace. 19:euw221-euw221. 2017
- Questioning patient engagement: research scientists’ perceptions of the challenges of patient engagement in a cardiovascular research network. Patient Preference and Adherence. Volume 11:1573-1583. 2017
- Stroke Prevention for Patients with Atrial Fibrillation: Beyond the Guidelines. Journal of Atrial Fibrillation. 9:1475. 2017
- At What Age Does Stroke Risk Increase in Patients With Atrial Fibrillation? Does It Depend on Where You Live?. Canadian Journal of Cardiology. 32:1364-1365. 2016
- High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme. Open Heart. 3:e000515-e000515. 2016
- Identifying Patients With Atrial Fibrillation in Administrative Data. Canadian Journal of Cardiology. 32:1561-1565. 2016
- The Canadian Arrhythmogenic Right Ventricular Cardiomyopathy Registry: Rationale, Design, and Preliminary Recruitment. Canadian Journal of Cardiology. 32:1396-1401. 2016
- 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. Canadian Journal of Cardiology. 32:1170-1185. 2016
- A New, Simplified Measure of Anticoagulation Control With Warfarin: Potential Role in the Direct Oral Anticoagulant Era. Canadian Journal of Cardiology. 32:1203.e5-1203.e7. 2016
- Canadian Registry of Implantable Electronic Device Outcomes. Circulation: Arrhythmia and Electrophysiology. 9:e004282. 2016
- Erratum to ‘2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter‐deﬁbrillator programming and testing’ [Journal of Arrhythmia 32/1 (2016) 1–28]. Journal of Arrhythmia. 32:441-442. 2016
- Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation?. Canadian Journal of Cardiology. 32:1203.e9-1203.e11. 2016
- Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 13:1964-1970. 2016
- Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims. Circulation: Arrhythmia and Electrophysiology. 9:e004274. 2016
- Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study. The Lancet. 388:1161-1169. 2016
- Letter by Hess et al Regarding Article, “How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring”. Circulation. 134:e28-e29. 2016
- Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. New England Journal of Medicine. 375:111-121. 2016
- The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis. Blood. 128:138-140. 2016
- Double twiddle trouble, a new variant of twiddler syndrome. Journal of Arrhythmia. 32:236-237. 2016
- Apical versus Non‐Apical Lead: Is ICD Lead Position Important for Successful Defibrillation?. Journal of Cardiovascular Electrophysiology. 27:581-586. 2016
- Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial. Circulation: Arrhythmia and Electrophysiology. 9:e003807. 2016
- North American Thrombosis Forum, AF Action Initiative Consensus Document. American Journal of Medicine. 129:S1-S29. 2016
- Response to Letter Regarding Article, “Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry”. Circulation: Arrhythmia and Electrophysiology. 9:e004012. 2016
- Subclinical Atrial Fibrillation and the Risk of Stroke (vol 366, pg 120, 2012). New England Journal of Medicine. 374:998-998. 2016
- Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection. Journal of the American College of Cardiology. 67:1300-1308. 2016
- Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial. American Heart Journal. 173:102-107. 2016
- Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial. Thrombosis Research. 139:77-81. 2016
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 13:e50-e86. 2016
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace. 18:159-183. 2016
- 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter‐defibrillator programming and testing. Journal of Arrhythmia. 32:1-28. 2016
- Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial. Heart Rhythm. 13:504-510. 2016
- Consistent Inconsistency? Is There Pacemaker Malfunction?. Journal of Cardiovascular Electrophysiology. 27:131-133. 2016
- Outcome of Apparently Unexplained Cardiac Arrest. Circulation: Arrhythmia and Electrophysiology. 9:e003619. 2016
- Complications of defibrillation testing. Herzschrittmachertherapie und Elektrophysiologie. 26:320-323. 2015
- Response to Letter Regarding Article, “Left Atrial Appendage Occlusion Debate Revisited”. Circulation. 132:e230. 2015
- Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial. International Journal of Cardiology. 196:127-131. 2015
- Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy. Heart Rhythm. 12:2148-2154. 2015
- Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators. Circulation. Heart Failure. 8:927-937. 2015
- How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society. ACP journal club. 163:382-385. 2015
- The Role of Defibrillation Testing. Cardiac Electrophysiology Clinics. 7:539-546. 2015
- Resetting of a Supraventricular Tachycardia by a Ventricular Premature Beat. What is the Mechanism?. PACE - Pacing and Clinical Electrophysiology. 38:1005-1008. 2015
- The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring. European Heart Journal. 36:1640-1642. 2015
- Prospective study of tricuspid valve regurgitation associated with permanent leads in patients undergoing cardiac rhythm device implantation: Background, rationale, and design. Global Cardiology Science and Practice. 2015:41-41. 2015
- A Systematic Review on the Progression of Paroxysmal to Persistent Atrial Fibrillation. JACC: Clinical Electrophysiology. 1:105-115. 2015
- Are We Ready for Mass Screening to Detect Atrial Fibrillation?. Circulation. 131:2167-2168. 2015
- Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Thrombosis and Haemostasis. 113:625-632. 2015
- Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke. Stroke. 46:936-941. 2015
- Meta‐Analysis of Continuous Oral Anticoagulants Versus Heparin Bridging in Patients Undergoing CIED Surgery: Reappraisal after the BRUISE Study. PACE - Pacing and Clinical Electrophysiology. 38:417-423. 2015
- Cost Effectiveness of Continued-Warfarin Versus Heparin-Bridging Therapy During Pacemaker and Defibrillator Surgery. Journal of the American College of Cardiology. 65:957-959. 2015
- Delayed AICD therapy and cardiac arrest resulting from undersensing of ventricular fibrillation in a subject with hypertrophic cardiomyopathy–A case report. Indian Pacing and Electrophysiology Journal. 15:121-124. 2015
- Insight into the mechanism of failure of the Riata lead under advisory. Heart Rhythm. 12:574-579. 2015
- Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure. Stroke. 46:667-672. 2015
- Safety of Urgent Cardioversion for Patients With Recent-Onset Atrial Fibrillation and Flutter. Canadian Journal of Cardiology. 31:239-241. 2015
- Left Atrial Appendage Occlusion Debate Revisited. Circulation. 131:756-761. 2015
- Response to Letter Regarding Article “Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events”. Circulation. 131:e337-e338. 2015
- Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE). The Lancet. 385:785-791. 2015
- Incidence, Predictors, and Procedural Results of Upgrade to Resynchronization Therapy. Circulation: Arrhythmia and Electrophysiology. 8:152-158. 2015
- Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. European Heart Journal. 36:281-288. 2015
- Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9–10, 2013. Heart Rhythm. 12:e5-e29. 2015
- Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation. PLoS ONE. 10:e0145579-e0145579. 2015
- Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker. Indian Pacing and Electrophysiology Journal. 15:62-64. 2015
- The New Canadian Cardiovascular Society Algorithm for Antithrombotic Therapy of Atrial Fibrillation Is Appropriately Based on Current Epidemiologic Data. Canadian Journal of Cardiology. 31:20-23. 2015
- Tricuspid Valve Regurgitation Following Temporary or Permanent Endocardial Lead Insertion, and the Impact of Cardiac Resynchronization Therapy. Open Cardiovascular Medicine Journal. 8:113-120. 2014
- Defibrillator discharges in a young patient: What is the underlying arrhythmia?. Heart Rhythm. 11:2202-2205. 2014
- Evaluation of Genes Encoding for the Transient Outward Current (Ito) Identifies the KCND2 Gene as a Cause of J-Wave Syndrome Associated With Sudden Cardiac Death. Circulation. Genomic and precision medicine. 7:782-789. 2014
- Interaction Between Digoxin and Dronedarone in the PALLAS Trial. Circulation: Arrhythmia and Electrophysiology. 7:1019-1025. 2014
- Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads. Heart Rhythm. 11:2156-2162. 2014
- Automatic Implantable Cardioverter Defibrillator Lead Dislodgement Resulting in Sudden Cardiac Death: A Case Report. Canadian Journal of Cardiology. 30:1460.e7-1460.e9. 2014
- VDD vs DDD Pacemakers: A Meta-analysis. Canadian Journal of Cardiology. 30:1385-1391. 2014
- 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. Canadian Journal of Cardiology. 30:1114-1130. 2014
- Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial. Thrombosis Research. 134:814-818. 2014
- Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study. Open Cardiovascular Medicine Journal. 8:94-101. 2014
- Predictors of early and late stroke following cardiac surgery. CANADIAN MEDICAL ASSOCIATION JOURNAL. 186:905-911. 2014
- Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke. Journal of the American Medical Association (JAMA). 312:616-616. 2014
- Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke (vol 312, pg 616, 2014). Journal of the American Medical Association (JAMA). 312:A616-A616. 2014
- Atrioventricular Block as the Initial Manifestation of Cardiac Sarcoidosis in Middle‐Aged Adults. Journal of Cardiovascular Electrophysiology. 25:875-881. 2014
- Oral Anticoagulant Use in Patients With Chronic Kidney Disease: How to Choose, and the Importance of Empiric Human Data. Canadian Journal of Cardiology. 30:853-854. 2014
- Greater Mortality Risk Among Patients With Delayed Follow-up After Implantable Cardioverter Defibrillator Procedures. Canadian Journal of Cardiology. 30:598-605. 2014
- Prevalence of risk factors for atrial fibrillation and stroke among 1210 patients with sleep disordered breathing. International Journal of Cardiology. 174:73-76. 2014
- Procainamide infusion in the evaluation of unexplained cardiac arrest: From the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Heart Rhythm. 11:1047-1054. 2014
- Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER).. Heart Rhythm. 11:1047-1054. 2014
- Snapshot of adult invasive cardiac electrophysiology in Canada: results of the web-based registry. Journal of Interventional Cardiac Electrophysiology. 40:93-98. 2014
- Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events. Circulation. 129:2094-2099. 2014
- Management of Anticoagulation Around Pacemaker and Defibrillator Surgery. Circulation. 129:2062-2065. 2014
- Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation. Circulation. 129:1688-1694. 2014
- Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries. Circulation. 129:1568-1576. 2014
- Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?. Circulation: Arrhythmia and Electrophysiology. 7:347-351. 2014
- Left Ventricular Lead Position and Outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Canadian Journal of Cardiology. 30:413-419. 2014
- Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2). Journal of the American Medical Association (JAMA). 311:692-692. 2014
- Response to Letter Regarding Article, “Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly”. Circulation. 129:e337-e338. 2014
- Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia. Heart Rhythm. 11:274-281. 2014
- Managing Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Device Surgery: Canadian Survey. Canadian Journal of Cardiology. 30:231-236. 2014
- Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III.. Annals of Cardiothoracic Surgery. 3:45-54. 2014
- Epitope mapping of inhibitory antibodies targeting the C2 domain of coagulation factor VIII by hydrogen–deuterium exchange mass spectrometry. Journal of Thrombosis and Haemostasis. 11:2128-2136. 2013
- Left Atrial Appendage Occlusion Study II (LAAOS II). Canadian Journal of Cardiology. 29:1443-1447. 2013
- [Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].. Giornale Italiano di Cardiologia. 14:724-725. 2013
- Device Surgery without Interruption of Anticoagulation. New England Journal of Medicine. 369:1570-1572. 2013
- Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus. JAMA Internal Medicine. 173:1682-1692. 2013
- Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis. Canadian Journal of Cardiology. 29:1203-1210. 2013
- The Canadian experience with Durata and Riata ST Optim defibrillator leads: A report from the Canadian Heart Rhythm Society Device Committee. Heart Rhythm. 10:1478-1481. 2013
- The Evolving Role of Stroke Prediction Schemes for Patients With Atrial Fibrillation. Canadian Journal of Cardiology. 29:1173-1180. 2013
- Right Ventricular Tachycardia. Circulation. 128:e85-e87. 2013
- How to Manage a High Defibrillation Threshold in ICD Patients: and Does it Really Matter?. Current Treatment Options in Cardiovascular Medicine. 15:497-505. 2013
- Isolated Cardiac Sarcoidosis: Establishing the Diagnosis With Electroanatomic Mapping-Guided Endomyocardial Biopsy. Canadian Journal of Cardiology. 29:1015.e1-1015.e3. 2013
- Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target. Canadian Journal of Cardiology. 29:S1-S3. 2013
- Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants. Canadian Journal of Cardiology. 29:S54-S59. 2013
- Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly. Circulation. 127:2383-2392. 2013
- Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation. New England Journal of Medicine. 368:2084-2093. 2013
- Failure rate of the Riata lead under advisory: A report from the CHRS Device Committee. Heart Rhythm. 10:692-695. 2013
- Atrial fibrillation is associated with increased mortality: causation or association?. European Heart Journal. 34:1027-1030. 2013
- Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion. Thrombosis Research. 131:300-303. 2013
- Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials. International Journal of Cardiology. 165:17-24. 2013
- Ethnic Differences in Atrial Fibrillation Identified Using Implanted Cardiac Devices. Journal of Cardiovascular Electrophysiology. 24:381-387. 2013
- Response to Letters Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. Circulation. 127:E506-E506. 2013
- Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”.. Circulation. 127:e506. 2013
- Reply to the Editor—Shocks and Mortality versus Pacing and Mortality. Heart Rhythm. 10:e9-e10. 2013
- Response to Letter Regarding Article, “Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation: Results From the Resynchronization for Ambulatory Heart Failure Trial (RAFT)”. Circulation. Heart Failure. 6:23-24. 2013
- Shocks and Mortality versus Pacing and Mortality Reply. Heart Rhythm. 10:E9-E10. 2013
- Bidirectional Ventricular Tachycardia Secondary to Subacute Myocarditis. Canadian Journal of Cardiology. 29:254.e13-254.e14. 2013
- Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection. Canadian Journal of Cardiology. 29:182-195. 2013
- Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral Anticoagulation. Canadian Journal of Cardiology. 29:224-228. 2013
- The Burden of Atrial Fibrillation on the Hospital Sector in Canada. Canadian Journal of Cardiology. 29:229-235. 2013
- Trifecta or Triple Threat? The Challenge of Post-PCI Management in Patients Receiving Chronic Oral Anticoagulant Therapy. Canadian Journal of Cardiology. 29:136-138. 2013
- Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Clinical Respiratory Journal. 2021:CD003611. 2013
- Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation. International Journal of Vascular Medicine. 2013:1-11. 2013
- Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial. Trials. 14:346-346. 2013
- Renal Sympathetic Denervation: Using an Old Tool for a New Job?. Revista Brasileira de Cardiologia Invasiva. 21:3-4. 2013
- A Randomized‐Controlled Pilot Study Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing in Patients with Heart Failure and Severe Left Ventricular Dysfunction: A Substudy of the RAFT Trial. Journal of Cardiovascular Electrophysiology. 23:1313-1316. 2012
- Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis. Journal of Interventional Cardiac Electrophysiology. 35:259-275. 2012
- Implantable cardioverter-defibrillator shock prevention does not reduce mortality: A systemic review. Heart Rhythm. 9:2068-2074. 2012
- Approaches to empiric ablation of slow pathway: results from the Canadian EP web survey. Journal of Interventional Cardiac Electrophysiology. 35:183-187. 2012
- Atrial overdrive pacing to prevent atrial fibrillation: Insights from ASSERT. Heart Rhythm. 9:1667-1673. 2012
- Epinephrine Infusion in the Evaluation of Unexplained Cardiac Arrest and Familial Sudden Death. Circulation: Arrhythmia and Electrophysiology. 5:933-940. 2012
- Heart failure in patients with sick sinus syndrome treated with single lead atrial or dual-chamber pacing: no association with pacing mode or right ventricular pacing site. Europace. 14:1475-1482. 2012
- Predictors of Atrio‐Ventricular Conduction Disease, Long‐Term Outcomes in Patients with Myotonic Dystrophy Types I and II. PACE - Pacing and Clinical Electrophysiology. 35:1262-1269. 2012
- Correction. Circulation. 126:E160-E160. 2012
- Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation. Circulation. Heart Failure. 5:566-570. 2012
- Reply to the Editor—Electrogram Confirmation of Atrial High-Rate Episodes. Heart Rhythm. 9:e17-e18. 2012
- Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: An analysis from ASSERT. Heart Rhythm. 9:1241-1246. 2012
- Relevance of Electrical Remodeling in Human Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 5:626-631. 2012
- The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: A randomized, controlled trial of defibrillation testing at the time of defibrillator implantation. American Heart Journal. 164:146-152. 2012
- Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin. Circulation. 126:343-348. 2012
- Erratum to: Society position statement. Canadian Journal of Anaesthesia. 59:730-730. 2012
- Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. Europace. 14:682-689. 2012
- Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies. Journal of Hypertension. 30:1004-1014. 2012
- Subclinical Atrial Fibrillation and the Risk of Stroke REPLY. New England Journal of Medicine. 366:1352-1353. 2012
- The authors reply. New England Journal of Medicine. 366:1352-1353. 2012
- Society position statement. Canadian Journal of Anaesthesia. 59:394-407. 2012
- Clinical Predictors of Fidelis Lead Failure. Circulation. 125:1217-1225. 2012
- Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society Joint Position Statement on the Perioperative Management of Patients With Implanted Pacemakers, Defibrillators, and Neurostimulating Devices. Canadian Journal of Cardiology. 28:141-151. 2012
- Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control. Canadian Journal of Cardiology. 28:125-136. 2012
- Gastroesophageal reflux and atrial fibrillation: is there any correlation?. Expert Review of Cardiovascular Therapy. 10:317-322. 2012
- Nonphysiologic noise early after defibrillator implantation in Canada: Incidence and implications. Heart Rhythm. 9:378-382. 2012
- Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database. ACP journal club. 156:195-195. 2012
- Are Elderly Patients at Increased Risk of Complications Following Pacemaker Implantation? A Meta‐Analysis of Randomized Trials. PACE - Pacing and Clinical Electrophysiology. 35:131-134. 2012
- Device-detected atrial tachyarrhythmias: what do we know?. Europace. 14:157-158. 2012
- Reply to Letters Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial”. Circulation. 125:E293-E294. 2012
- Subclinical Atrial Fibrillation and the Risk of Stroke. New England Journal of Medicine. 366:120-129. 2012
- Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses.. CADTH technology overviews. 2:e2101. 2012
- Does catheter ablation for atrial fibrillation increase or reduce neurological insult?. Current Opinion in Cardiology. 27:36-40. 2012
- Sentinel Symptoms in Patients with Unexplained Cardiac Arrest: From the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Journal of Cardiovascular Electrophysiology. 23:60-66. 2012
- Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation. Journal of Internal Medicine. 271:15-24. 2012
- Dronedarone in High-Risk Permanent Atrial Fibrillation. New England Journal of Medicine. 365:2268-2276. 2011
- Antiarrhythmic Drug Therapy for New-Onset Ventricular Arrhythmia (VT/VF) in ICD Patients. Cardiac Electrophysiology Clinics. 3:651-661. 2011
- Derivation and Validation of a Simple Exercise-Based Algorithm for Prediction of Genetic Testing in Relatives of LQTS Probands. Circulation. 124:2187-2194. 2011
- Entrainment of supraventricular tachycardia: What is the mechanism?. Heart Rhythm. 8:1809-1811. 2011
- Prevalence and Risk Factors for Cervical and Lumbar Spondylosis in Interventional Electrophysiologists. Journal of Cardiovascular Electrophysiology. 22:957-960. 2011
- Prevalence and Characteristics of Early Repolarization in the CASPER Registry. Journal of the American College of Cardiology. 58:722-728. 2011
- Catheter Ablation of Hemodynamically Unstable Ventricular Tachycardia in a Patient with Dextro - Transposition of the Great Arteries and Mustard's Repair.. Indian Pacing and Electrophysiology Journal. 11:120-125. 2011
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation. Circulation. 123:2363-2372. 2011
- Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement. Circulation: Arrhythmia and Electrophysiology. 4:136-142. 2011
- Response to Letter Regarding Article, “Complications Associated With Revision of Sprint Fidelis Leads: Report From the Canadian Heart Rhythm Society Device Advisory Committee”. Circulation. 123:E376-E377. 2011
- Irbesartan in Patients with Atrial Fibrillation. New England Journal of Medicine. 364:928-938. 2011
- Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials. CANADIAN MEDICAL ASSOCIATION JOURNAL. 183:421-429. 2011
- A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. European Heart Journal. 32:686-696. 2011
- Recommendations for the Use of Genetic Testing in the Clinical Evaluation of Inherited Cardiac Arrhythmias Associated with Sudden Cardiac Death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Paper. Canadian Journal of Cardiology. 27:232-245. 2011
- The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation. Europace. 13:409-415. 2011
- Contralateral Pneumothorax in Left Sided CRT Device Implantation.. Indian Pacing and Electrophysiology Journal. 11:16-19. 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations. Canadian Journal of Cardiology. 27:31-37. 2011
- Do omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials.. Clinics. 66:1923-1928. 2011
- Troponin Elevation in Patients With Supraventricular Tachycardia: What Does It Mean?. Canadian Journal of Cardiology. 27:110-111. 2011
- Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure. New England Journal of Medicine. 363:2385-2395. 2010
- Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry. Journal of Cardiovascular Electrophysiology. 21:1344-1348. 2010
- A rare cause of implantable cardioverter-defibrillator failure: Short-circuiting via an unused pace/sense lead. Heart Rhythm. 7:1630-1631. 2010
- Epsilon Waves During Ventricular Tachycardia in a Case of Arrhythmogenic Right Ventricular Dysplasia. Circulation. 122:1752-1755. 2010
- Device‐Related Infection Among Patients With Pacemakers and Implantable Defibrillators: Incidence, Risk Factors, and Consequences. Journal of Cardiovascular Electrophysiology. 21:786-790. 2010
- Erratum to: New pharmacotherapy for stroke prevention in atrial fibrillation. Advances in Therapy. 27:493-493. 2010
- Complications Associated With Revision of Sprint Fidelis Leads. Circulation. 121:2384-2387. 2010
- Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing. Journal of Cardiovascular Electrophysiology. 21:177-182. 2010
- Evaluation of Early Complications Related to De Novo Cardioverter Defibrillator Implantation. Journal of the American College of Cardiology. 55:774-782. 2010
- New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010. Advances in Therapy. 26:1058-1071. 2009
- Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin. Circulation. 120:1927-1932. 2009
- Left Atrial Appendage Occlusion Eliminates the Need for Warfarin. Circulation. 120:1919-1926. 2009
- Left Atrial Appendage Occlusion Eliminates the Need for Warfarin Response to Holmes and Schwartz. Circulation. 120:1926-1926. 2009
- Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada. Heart Rhythm. 6:1276-1279. 2009
- Atrial overdrive pacing in sleep apnoea: a meta-analysis. Europace. 11:1037-1040. 2009
- Systematic Assessment of Patients With Unexplained Cardiac Arrest. Circulation. 120:278-285. 2009
- Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee. Canadian Journal of Cardiology. 25:403-405. 2009
- The Prognostic Significance of Bundle Branch Block in High‐Risk Chronic Stable Vascular Disease Patients: A Report from the HOPE Trial. Journal of Cardiovascular Electrophysiology. 20:781-787. 2009
- A Case of Long‐RP Tachycardia: What is the Mechanism?. Journal of Cardiovascular Electrophysiology. 20:702-704. 2009
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation. New England Journal of Medicine. 360:2066-2078. 2009
- Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: The Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 6:474-477. 2009
- Postoperative Low‐Molecular‐Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators. PACE - Pacing and Clinical Electrophysiology. 32:378-382. 2009
- A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 20:138-144. 2009
- Bad lead? Good lead? What should we believe?. Heart Rhythm. 6:210-211. 2009
- Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design. Current Opinion in Cardiology. 24:82-87. 2009
- Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”. Thrombosis and Haemostasis. 102:912-913. 2009
- Outcome of advisory implantable cardioverter-defibrillator replacement: One-year follow-up. Heart Rhythm. 5:1675-1681. 2008
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range. Circulation. 118:2029-2037. 2008
- Life and Death after ICD Implantation. New England Journal of Medicine. 359:1058-1059. 2008
- Design and implementation of a population-based registry of implantable cardioverter defibrillators (ICDs) in Ontario. Heart Rhythm. 5:1250-1256. 2008
- Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. The Lancet. 372:1174-1183. 2008
- Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: A report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 5:639-642. 2008
- Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. Stroke. 39:1482-1486. 2008
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. New England Journal of Medicine. 358:1547-1559. 2008
- Complications associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm. 5:387-390. 2008
- Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy. Journal of the American College of Cardiology. 50:2156-2161. 2007
- Coronary artery disease - Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study. American Heart Journal. 154:448-453. 2007
- Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study. American Heart Journal. 154:448-453. 2007
- The effect of atrial-based pacing on exercise capacity as measured by the 6-minute walk test: A substudy of the Canadian Trial of Physiological Pacing (CTOPP). Heart Rhythm. 4:1024-1028. 2007
- Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. European Heart Journal. 28:1746-1749. 2007
- Preventing tomorrow's sudden cardiac death today. American Heart Journal. 153:951-959. 2007
- Preventing tomorrow's sudden cardiac death today. American Heart Journal. 153:941-950. 2007
- Right ventricular apical pacing: a necessary evil?. Current Opinion in Cardiology. 22:33-38. 2007
- Omega-3 fatty acids and sudden arrhythmic death.. Herz. 31 Suppl 3:59-64. 2006
- ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). American Heart Journal. 152:442-447. 2006
- Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing. Circulation. 114:11-17. 2006
- Clinical trials, the renin angiotensin system and atrial fibrillation. Current Opinion in Cardiology. 21:368-375. 2006
- Universal access – but when? Treating the right patient at the right time: Access to electrophysiology services in Canada. Canadian Journal of Cardiology. 22:741-746. 2006
- Benefits of left atrial appendage occlusion. American Heart Journal. 151:e3-e3. 2006
- Stroke prevention in patients with atrial fibrillation: The diagnosis and management of hypertension by specialists. Canadian Journal of Cardiology. 22:485-488. 2006
- Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes. New England Journal of Medicine. 354:1464-1476. 2006
- Reply. Journal of the American College of Cardiology. 47:890-891. 2006
- Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. American Heart Journal. 150:288-293. 2005
- Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Journal of the American College of Cardiology. 45:1832-1839. 2005
- Cost-effectiveness of physiologic pacing: Results of the Canadian Health Economic Assessment of Physiologic Pacing. Heart Rhythm. 2:270-275. 2005
- Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.. Current Opinion in Cardiology. 20:31-37. 2005
- Human Study of Biatrial Electrical Coupling. Circulation. 110:2083-2089. 2004
- The management of patients with carotid sinus syndrome: is pacing the answer?. Clinical Autonomic Research. 14:i80-i86. 2004
- Physiologic pacing: where pacing mode selection reflects the indication. Heart. 90:593-594. 2004
- Improvement of apparently fixed pulmonary hypertension with cardiac resynchronization therapy. The Journal of Heart and Lung Transplantation. 23:650-652. 2004
- Reverse atrial electrical remodelling following atrial defibrillation as determined by signal-averaged ECG.. Canadian Journal of Cardiology. 20:311-315. 2004
- Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target.. American Journal of Cardiology. 91:9G-14G. 2003
- Off-Pump Coronary Bypass Surgery. New England Journal of Medicine. 348:1928-1931. 2003
- Off-pump coronary bypass surgery. New England Journal of Medicine. 348:1929-1930. 2003
- Prognostic use of cardiac troponin T and troponin I in patients with heart failure.. Canadian Journal of Cardiology. 19:383-386. 2003
- Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions.. Journal of Interventional Cardiac Electrophysiology. 7:189-192. 2003
- Thiamine deficiency in congestive heart failure patients receiving long term furosemide therapy.. Journal of Population Therapeutics and Clinical Pharmacology. 10:184-188. 2003
- Pacemakers, recent directions and developments. Current Opinion in Anaesthesiology. 15:681-686. 2002
- Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis.. Cochrane Database of Systematic Reviews. 106:75-80. 2002
- The Spectrum of Intramyocardial Small Vessel Disease Associated with Sudden Death. Journal of Forensic Sciences. 47:384-388. 2002
- DISTANCE LIBRARY-EDUCATION. Library Trends. 39:424-440. 1991
- ADVERTISING SCREAMERS VERSUS HUMMERS. Journal of Advertising Research. 26:43-49. 1987
- Advertising Substantiation and Advertiser Response: A Content Analysis of Magazine Advertisements. Journal of Marketing. 47:107-107. 1983
- RESEARCH AND THE READERS GUIDE - INVESTIGATION INTO THE RESEARCH USE OF PERIODICALS INDEXED IN THE READERS GUIDE TO PERIODICAL LITERATURE. Serials Librarian. 3:179-190. 1978